Current directions for COX-2 inhibition in breast cancer (Q34498282)

2 August 2017

1 reference

title

Current directions for COX-2 inhibition in breast cancer (English)

1 reference

2 August 2017

Chow LW

1

1 reference

PubMed ID

16507393

2 August 2017

Loo WT

series ordinal

2

1 reference

PubMed ID

16507393

2 August 2017

Toi M

series ordinal

3

1 reference

2 August 2017

1 October 2005

1 reference

Biomedicine and Pharmacotherapy

2 August 2017

1 reference

2 August 2017

59 Suppl 2

1 reference

2 August 2017

S281-4

1 reference

Ethnicity and breast cancer: factors influencing differences in incidence and outcome

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Lifestyle and medical approaches to cancer prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Are all aromatase inhibitors the same? A review of the current evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Can erythropoietin therapy improve survival?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Role of aromatase inhibitors in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

A review of mammary ductoscopy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Implementation of capecitabine (Xeloda) into a cancer centre: UK experience

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Taxanes in elderly breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Intraopertive radiation therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Challenges in the endocrine management of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Role of cyclooxygenase-2 in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Paclitaxel: epirubicin in metastatic breast cancer--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Use of aromatase inhibitors in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

The antiprogesterone steroid, RU 486 (mifepristone).

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Cyclooxygenases in the skin: pharmacological and toxicological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

The role of COX-2 inhibition in breast cancer treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Cyclooxygenase-2: a potential target in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Relationship between expression and distribution of cyclooxygenase-2 and bcl-2 in human gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Induction of apoptosis and inhibition of cyclooxygenase-2 expression by N-methyl-N'-nitro-N-nitrosoguanidine in human leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Novel endocrine therapies in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Neoadjuvant endocrine therapy as a drug development strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Novel sensitizing agents: potential contribution of COX-2 inhibitor for endocrine therapy of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Nitric oxide signaling in colon cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1,

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Anti-angiogenic therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Beta-catenin--a linchpin in colorectal carcinogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Endocrine and clinical endpoints of exemestane as neoadjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Aberrant expression of aromatase in breast cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Biochemical control of breast aromatase

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Aromatase and COX-2 expression in human breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Aromatase and prostaglandin inter-relationships in breast adipose tissue: significance for breast cancer development

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Control of aromatase in breast cancer cells and its importance for tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Effects of matrix components on aromatase activity in breast stromal cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Aromatase and cyclooxygenases: enzymes in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2805%2980046-0

7 January 2021

10.1016/S0753-3322(05)80046-0

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

16507393